Search results for "Coronavirus"


 
Results 101 - 110 of about 237 for "Coronavirus".
Sort by: Relevance | Newest | Oldest

Latest COVID-19 research looks at tocilizumab, remdesivir, tracheostomy, readmissions

A living systematic review still didn't find benefit from remdesivir or tocilizumab, but new trials supported their use. Delaying tracheostomy may not help patients or clinicians, another study found, and the first 10 days carry increased readmission risk for COVID-19 patients.
https://acphospitalist.acponline.org/weekly/archives/2020/12/23/1.htm
23 Dec 2020

Latest research on COVID-19 antibodies, cardiac and stroke risks, mortality rates

Cardiac effects appeared common while strokes were not, mortality improved, a monoclonal antibody treatment showed benefit in outpatients, and data varied on duration of antibody response, among other recent findings on COVID-19.
https://acphospitalist.acponline.org/weekly/archives/2020/11/04/1.htm
4 Nov 2020

COVID-19 studies offer risk scores, experts issue guidance on vaccine prioritization

One study found that albumin was key to identifying COVID-19 patients safe to discharge, while another suggested CT findings could be helpful in diagnosis and triage. The Advisory Committee on Immunization Practices and ACP considered who should be vaccinated first, and the CDC revised quarantine advice.
https://acphospitalist.acponline.org/weekly/archives/2020/12/09/1.htm
9 Dec 2020

COVID-19 in community hospitals

Hospitalists describe the steps they've taken to prepare for the pandemic.
https://acphospitalist.acponline.org/archives/2020/04/covid-19-in-community-hospitals.htm
15 Apr 2020

One of us

I was shocked, not only by losing this skilled RN and unique man, but also by how deeply his death affected me as a hospitalist, as a person.
https://acphospitalist.acponline.org/archives/2020/11/one-of-us.htm
15 Nov 2020

COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk

Flu testing and treatment advice came from the NIH, convalescent plasma failed in a trial, new studies suggested looking out for myocardial injury and not overdoing thromboprophylaxis, and remdesivir got full approval, among other COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2020/10/28/1.htm
28 Oct 2020

Latest research, recommendations cover diabetes, clots, and remdesivir in COVID-19

Mortality was lower in diabetes patients given sitagliptin at admission for COVID-19, ACP practice points support remdesivir, acquired thrombophilia does not predict clots, cardiac arrest survival is low, and admissions for other conditions were still way down over the summer.
https://acphospitalist.acponline.org/weekly/archives/2020/10/07/1.htm
7 Oct 2020

IDSA guideline updates recommendations on dexamethasone, remdesivir, other drugs

The Infectious Diseases Society of America (IDSA) updated its recommendations on treatment and management of inpatients with COVID-19. An article by mental health experts offered guidance on talking with bereaved family members.
https://acphospitalist.acponline.org/weekly/archives/2020/07/01/1.htm
1 Jul 2020

Rise in HAIs during the pandemic, guidance on monoclonal antibodies for COVID-19

A new study found significant growth in health care-associated infections (HAIs), especially central line-associated bloodstream infections, during 2020, and the NIH offered advice on prioritization when monoclonal antibodies can't be given to all eligible patients.
https://acphospitalist.acponline.org/weekly/archives/2021/09/15/1.htm
15 Sep 2021

Hospitalist IMGs in the pandemic

Concerns about visas and residency add to pressures of hospitalist practice.
https://acphospitalist.acponline.org/archives/2020/04/hospitalist-imgs-in-the-pandemic.htm
15 Apr 2020

Result Page: Prev   6   7   8   9   10   11   12   13   14   15   Next